| Product Code: ETC13333594 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Nuclear Medicines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Nuclear Medicines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Nuclear Medicines Market - Industry Life Cycle |
3.4 Europe Nuclear Medicines Market - Porter's Five Forces |
3.5 Europe Nuclear Medicines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 Europe Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Europe Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Nuclear Medicines Market Trends |
6 Europe Nuclear Medicines Market, 2021 - 2031 |
6.1 Europe Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Nuclear Medicines Market, Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031 |
6.1.3 Europe Nuclear Medicines Market, Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031 |
6.2 Europe Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Nuclear Medicines Market, Revenues & Volume, By Oncology Imaging, 2021 - 2031 |
6.2.3 Europe Nuclear Medicines Market, Revenues & Volume, By Thyroid Treatment, 2021 - 2031 |
6.2.4 Europe Nuclear Medicines Market, Revenues & Volume, By Cardiac Imaging, 2021 - 2031 |
6.2.5 Europe Nuclear Medicines Market, Revenues & Volume, By Bone Pain Palliation, 2021 - 2031 |
6.3 Europe Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Nuclear Medicines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Nuclear Medicines Market, Revenues & Volume, By Endocrinology Clinics, 2021 - 2031 |
6.3.4 Europe Nuclear Medicines Market, Revenues & Volume, By Cardiology Centers, 2021 - 2031 |
6.3.5 Europe Nuclear Medicines Market, Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031 |
6.4 Europe Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Nuclear Medicines Market, Revenues & Volume, By Technetium-99m, 2021 - 2031 |
6.4.3 Europe Nuclear Medicines Market, Revenues & Volume, By Iodine-131, 2021 - 2031 |
6.4.4 Europe Nuclear Medicines Market, Revenues & Volume, By Thallium-201, 2020 - 2028 |
6.4.5 Europe Nuclear Medicines Market, Revenues & Volume, By Samarium-153, 2020 - 2028 |
7 Europe Nuclear Medicines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Nuclear Medicines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
7.3.1 United Kingdom (UK) Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.2 Germany Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.3 France Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.4 Poland Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.5 Spain Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.6 Rest of Europe Nuclear Medicines Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.4 Europe Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Nuclear Medicines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.2 Germany Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.3 France Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.4 Poland Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.5 Spain Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.6 Rest of Europe Nuclear Medicines Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8 Europe Nuclear Medicines Market Key Performance Indicators |
9 Europe Nuclear Medicines Market - Export/Import By Countries Assessment |
10 Europe Nuclear Medicines Market - Opportunity Assessment |
10.1 Europe Nuclear Medicines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.4 Europe Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
11 Europe Nuclear Medicines Market - Competitive Landscape |
11.1 Europe Nuclear Medicines Market Revenue Share, By Companies, 2022 |
11.2 Europe Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here